Denmark central bank raises 2026 GDP forecast to 4% on pharma output

Denmark's central bank revised its 2026 GDP growth forecast sharply upward to 4% from 1.8% in March, driven by increased pharmaceutical production, notably from Novo Nordisk. The revision signals a significant supply-side boost to the Danish economy, though it may be concentrated in a single sector.